Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dexpanthenol + sodium hyaluronate is a fixed-dose combination of two active ingredients used primarily in topical formulations for ocular and nasal applications. Dexpanthenol (a provitamin of pantothenic acid) acts as a moisturizer, protectant, and wound healing agent by promoting fibroblast proliferation and accelerating re-epithelialization. Sodium hyaluronate (the sodium salt of hyaluronic acid) is a naturally occurring glycosaminoglycan with strong water-binding capacity that forms a protective film on mucosal surfaces or the cornea, providing lubrication, moisture retention, anti-inflammatory effects, and supporting tissue repair. The combination is designed to enhance epithelial healing (notably after corneal injury or surgery), relieve symptoms of dry eyes or nasal dryness/irritation due to environmental factors or disease states such as allergic rhinitis or upper respiratory tract infections. Clinical studies have shown that this combination promotes faster corneal reepithelialization and nerve regeneration compared to monotherapy with sodium hyaluronate[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexpanthenol + sodium hyaluronate.